Pages that link to "Q38126674"
Jump to navigation
Jump to search
The following pages link to Neuromyelitis optica: concept, immunology and treatment (Q38126674):
Displaying 11 items.
- Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications (Q26768649) (← links)
- Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature (Q33734731) (← links)
- MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis. (Q34197306) (← links)
- Significant Association Between Fc Receptor-Like 3 Polymorphisms (-1901A>G and -658C>T) and Neuromyelitis Optica (NMO) Susceptibility in the Chinese Population (Q35540930) (← links)
- Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes (Q35780751) (← links)
- Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases (Q36511714) (← links)
- Immunoinflammatory diseases of the central nervous system - the tale of two cytokines (Q36547012) (← links)
- Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders (Q37209820) (← links)
- Postnatal outcome and placental blood flow after plasmapheresis during pregnancy. (Q48177205) (← links)
- Early initiation of steroid pulse therapy for neuromyelitis optica in an emergency room setting (Q89205731) (← links)
- Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects (Q93014536) (← links)